Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.917
S.917: Short on Competition Act
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced March 23, 2021
- Latest Major Action March 23, 2021
- See the two similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
3 (1 Democrat, 2 Republicans)
Bill Version
- Introduced in Senate - March 23, 2021
Bill Summary
Short on Competition Act This bill requires the Food and Drug Administration (FDA) to provide temporary authorization to import certain prescription drugs facing shortages or in a marginally competitive drug market. Specifically, the FDA shall authorize importation of an eligible drug that is lifesaving, life-sustaining, or intended to treat or prevent a debilitating condition. To be eligible, a drug must (1) be facing a shortage, (2)...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
March 23, 2021 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
March 23, 2021 |
Introduced in the Senate by Amy Klobuchar (D-Minn.) |